News

Could YOU make a pile of cash investing in the never-ending craze for Mounjaro and Ozempic?
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
Could YOU make a pile of cash from the never-ending craze for Mounjaro and Ozempic? ANNE ASHWORTH reveals everything you need to know
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly)
Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.
The Mirror US on MSN3h
Infertile mom 'beyond shocked' as Mounjaro jab results in miracle baby
While there is no clear evidence that GLP-1 medications can increase chances of pregnancy, there is a strong correlation ...
India defies global gloom: Domestic, health demand drive long-term growth
Enter global pharmaceutical giants. US-based Eli Lilly and Novo Nordisk have both launched GLP-1-based treatments in India in ...
Ozempic in a pill? The next generation of weight-loss drugs emerges
Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...
Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
Amgen Inc. (NASDAQ: AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street’s reaction to the company’s latest data announcement regarding MariTide, ...
Weighing in on weight-loss drugs
Two new injectable drugs offer hope to the obese, especially diabetics, and could set off a pharma race to cash in on the ...